Celltrion Healthcare Co Ltd
KOSDAQ:091990
Celltrion Healthcare Co Ltd
KOSDAQ:091990
Price:
75 900
KRW
-5.6%
Market Cap:
₩12.5T
Relative Value
There is not enough data to reliably calculate the relative value of Celltrion Healthcare Co Ltd.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
Not Available
Multiples Across Competitors
Competitors Multiples
Celltrion Healthcare Co Ltd Competitors
Celltrion Healthcare Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
122.5B USD | 0.3 | 28.2 | 19.8 | 22.2 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
71.9B USD | 0.2 | 44.2 | 15.5 | 19.6 | |
| US |
|
Cencora Inc
NYSE:COR
|
72.5B USD | 0.2 | 44.7 | 15.6 | 19.7 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
53.6B USD | 0.2 | 32.3 | 15.5 | 20.1 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
31.4B AUD | 2.8 | 35.1 | 26 | 26 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.4B USD | 0.7 | 23.3 | 11.3 | 16 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.8B CNY | 0.2 | 11.3 | 15.2 | 15.2 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
60.2B CNY | 1.4 | 16.3 | 12.6 | 12.6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
65.2B HKD | 0.1 | 8.4 | 1.5 | 1.9 | |
| AU |
E
|
EBOS Group Ltd
OTC:EBOSY
|
7.7B USD | 0.9 | 50.4 | 28.8 | 28.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
